Suxamethonium Chloride Ethypharm

Suxamethonium Chloride Ethypharm contains suxamethonium chloride dihydrate for intravenous use in medical procedures. This short-acting neuromuscular blocking agent helps relax muscles during intubation or surgery. It is supplied as a sterile solution for rapid onset and brief duration. Suitable for clinical settings requiring controlled muscle relaxation.

Suxamethonium chloride is primarily used to induce muscle relaxation during endotracheal intubation or surgical procedures. It is often administered in emergency or controlled medical settings where temporary paralysis of skeletal muscles is required. The drug’s rapid onset and short duration make it suitable for brief procedures or as part of anesthesia protocols. It is not intended for routine pain relief or long-term use.

When administered intravenously, suxamethonium chloride causes rapid muscle relaxation by mimicking acetylcholine at the neuromuscular junction. This effect typically begins within 30 to 60 seconds and lasts for approximately 5 to 10 minutes. Patients may experience temporary muscle weakness or fasciculations before full relaxation occurs. Recovery is usually spontaneous as the drug is quickly metabolized.

Suxamethonium chloride should only be administered by trained healthcare professionals in a clinical setting equipped for airway management. Patients with a history of malignant hyperthermia or significant burns may require special consideration. Close monitoring of respiratory and cardiovascular function is essential during and after administration. Ensure emergency airway equipment is readily available.

Concurrent use with certain antibiotics, such as aminoglycosides, may enhance neuromuscular blocking effects. Drugs like magnesium sulfate or lithium can also prolong paralysis. General anesthetics, including volatile agents, may potentiate the effects of suxamethonium chloride. Always inform healthcare providers of all medications being taken before administration.